Simplex Trading, LLC Lyell Immunopharma, Inc. Transaction History

Simplex Trading, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$1.3 - $3.01 $4,370 - $10,119	3,362 New	3,362 $4,000
Q3 2023 Nov 01, 2023	BUY	$1.45 - $3.35 $801 - $1,852	553 New	553 $0
Q1 2023 Apr 27, 2023	BUY	$1.97 - $3.58 $35 - $64	18 New	18 $0
Q3 2022 Nov 04, 2022	SELL	$5.54 - $8.27 $18,282 - $27,291	-3,300 Reduced 97.69%	78 $0
Q2 2022 Aug 03, 2022	SELL	$3.68 - $6.8 $1,968 - $3,638	-535 Reduced 13.67%	3,378 $22,000
Q1 2022 May 02, 2022	BUY	$5.05 - $7.7 $11,488 - $17,517	2,275 Added 138.89%	3,913 $19,000
Q4 2021 Feb 23, 2022	BUY	$7.13 - $15.19 $11,678 - $24,881	1,638 New	1,638 $12,000

121

142M

18.1K

200

Ticker LYEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 247,824,992
Market Cap $151M
Description
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.